Cyto Pulse Sciences, Inc
Contact
Laboratory Research Systems

  • 7-9 October 2009
    Yokohama, Japan
    BioJapan 2009
    Business Partnering

More Events...

  • Cyto Pulse, the Karolinska Hospital/Institutet and SMI Receive Approval from the Swedish Medical Products Agency to Start a Clinical Trial Evaluating a CEA-based Vaccine in Patients with Colorectal Cancer
    See Press Release for
    more information...

Prostate cancer Press Release More Press Releases

 
 

Cyto Pulse Sciences, Inc. is a medical device and treatment development company dedicated to advancing quality of life through novel electric field based technologies to produce and deliver new medicine therapeutics (polynucleotides) for:

Cancer treatments (immunotherapy)

Protection against infectious diseases (prophylaxis therapy)

Correcting a genetic defect
(gene therapy)

Cyto Pulse Pipeline
 
 
Cyto Pulse Sciences  Contact Info
 


 

Commercial and Clinical Technology Laboratory Research Systems DNA Vaccine Delivery mAb Discovery Large Volume Transfection Veterinary Oncology Home Company News Science Contact Site Map Cyto Pulse Pipeline Cyto Pulse Pipeline Cyto Pulse Pipeline